Ambiotis is a pre-clinical CRO focused on inflammation and with a worldwide recognized expertise on the resolution phase of inflammation. Ambiotis provides state-of-the-art bioassay and analytical services to detect and quantify specific biomarkers of the different phases of inflammatory/resolution process, to bring proof of concept of ingredients/molecules efficacy and to establish the mechanism of action in an innovative way.
Ambiotis also provides lipidomics service, especially for the quantification of the main cutaneous lipids (ceramides, wax esters, squalene, cholesterol, cholesteryl ester, free fatty acids, total fatty acids…)